London, UK – November 14, 2018. Raremark has today joined the London Stock Exchange Group’s ELITE program, an ecosystem designed to help private companies prepare and structure for the next stage of growth. Over the next 12 months, Raremark will receive specialist business education from Imperial College London, as well as advice across a range […]
Raremark, the leading patient-data platform in rare disease, has raised £3m in funding from investors, led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and from existing major investor the Cass Entrepreneurship Fund.
London, UK – October 10, 2017. Medical research can move from good to great if families affected by a rare disease are treated as partners in the clinical trial process, argues a Raremark white paper published today. It has been about ten years since the first pioneers used the internet to advise patients directly about […]
Julie Walters shortlisted for Entrepreneur for Good by the NatWest Great British Entrepreneur Awards
London, UK – September, 12 2017. Raremark founder, Julie Walters, has been shortlisted for Entrepreneur for Good by the 2017 NatWest Great British Entrepreneur Awards, which take place in London on November 21. The awards have celebrated some outstanding entrepreneurs who have gone on to become household names, such as Ed Bussey from Quill and David […]
London, UK – June 15, 2017. Raremark founder, Julie Walters, won the award for Outstanding Female Entrepreneur at the Enterprise Awards, in London last night. The awards celebrate some of the most successful technology entrepreneurs in the UK & Ireland and are known as “the Oscars for Technology Entrepreneurs”. Julie is the driving force behind […]
London, UK – May 19, 2017. Education to help physicians recognize the symptoms of rare medical conditions, alongside cultural change within the medical profession, are key to shortening diagnostic odysseys in rare disease, argues a Raremark white paper published today. Recent qualitative research has shed light on the diverse routes to diagnosis experienced by members […]